Todas as matérias desta seção, das mais recentes às mais antigas — página 258 de 371.
Acacia Research (NASDAQ:ACTG), a diversified holding company that acquires and operates businesses across the industrial and technology sectors, reported fourth-quarter and full-year 2025 financial results on Wednesday.
Minerva Neurosciences (NASDAQ:NERV), a biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, reported a net loss of $283.7 million for the fourth quarter ended December 31, 2025.
Kamada (NASDAQ:KMDA), a vertical integrated biopharmaceutical company specializing in plasma-derived therapeutics, reported fourth-quarter and full-year 2025 financial results on Wednesday.
Verrica Pharmaceuticals (NASDAQ:VRCA), a dermatology-focused therapeutics company, reported financial results for the fourth quarter and full year ended December 31, 2025, on Wednesday.
Sonida Senior Living (NYSE:SNDA), an owner and operator of senior housing communities, announced its financial results for the fourth quarter and full year ended December 31, 2025, on Wednesday.
Sagimet Biosciences (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors, reported its fourth-quarter and full-year 2025 financial results on Wednesday.
BrainsWay (NASDAQ:BWAY), a global leader in advanced non-invasive neurostimulation treatments, reported robust financial results for the fourth quarter and full year ended December 31, 2025.
60 Degrees Pharmaceuticals (NASDAQ:SXTP), a specialist in medicines for vector-borne diseases, announced Wednesday that all three patients enrolled in its expanded-use clinical trial for relapsing babesiosis were successfully cured.
Broadwind (NASDAQ:BWEN), a diversified precision manufacturer of specialized components for the energy and mining industries, reported financial results for the fourth quarter and full year ended December 31, 2025.
The Campbell’s Company (NASDAQ:CPB) reported second-quarter fiscal 2026 results on Wednesday, revealing a challenging operating environment that prompted management to update its full-year guidance.
Smith Douglas Homes (NYSE:SDHC), one of the fastest-growing private homebuilders in the United States, reported financial results for the fourth quarter and full year ended December 31, 2025.
Sprinklr (NYSE:CXM), the unified customer experience management (Unified-CXM) platform, on Wednesday reported financial results for its fourth quarter and fiscal year ended January 31, 2026.
Serve Robotics (NASDAQ:SERV), a leader in autonomous sidewalk delivery, reported fourth-quarter and full-year 2025 financial results on Wednesday that exceeded its previous forecasts.
TSS (NASDAQ:TSSI), a prominent data center services provider specializing in high-performance computing, delivered record-breaking financial results for the fiscal year ended December 31, 2025.
Tesla (NASDAQ:TSLA) reported on Wednesday that sales of its China-made electric vehicles rose for a fourth consecutive month in February, significantly outpacing prior-year figures.
Cintas (NASDAQ:CTAS) announced on Wednesday that it has entered into a definitive agreement to acquire rival UniFirst (NYSE:UNF) for $310 per share.
Hyperscale Data (NYSE:GPUS) issued aggressive financial guidance for fiscal year 2026 on Wednesday, signaling a transformative year for the diversified holding company.
High Templar Tech (NYSE:HTT) reported unaudited financial results for the fourth quarter and full year ended December 31, 2025, revealing the significant fiscal impact of its ongoing strategic transition.
Katapult Holdings (NASDAQ:KPLT), an e-commerce focused lease-to-own (LTO) platform, reported its fourth-quarter and full-year 2025 financial results on Wednesday.
Korea Electric Power (NYSE:KEP), the state-run utility provider for the Republic of Korea, reported a net income of $914.2 million for the fourth quarter of 2025 on Wednesday.
JOYY (NASDAQ:JOYY), a leading global technology company operating popular social media platforms including Bigo Live and Likee, reported fourth-quarter 2025 revenue of $581.9 million on Wednesday.
Phoenix New Media (NYSE:FENG), a digital media company in China, reported a net income of $6.5 million for the fourth quarter of 2025 on Wednesday.
Tenax Therapeutics (NASDAQ:TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases, announced a major clinical milestone in its Phase 3 LEVEL trial.
Stagwell (NASDAQ:STGW), the challenger marketing network led by Chairman and CEO Mark Penn, reported fourth-quarter net income of $12.7 million on Tuesday, signaling a successful pivot toward AI-integrated marketing services.
